Fecal microbiota therapy in recurrent and refractory clostridium difficile infections has been associated with positive results in immunocompromised patients

Authors

Eric Applebach, Wayne State University School of MedicineFollow

Abstract

A critical appraisal and clinical application of Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. The American Journal of Gastroenterology, 2014;109(7):1065-71. doi: 10.1038/ajg.2014.133

DOI

10.22237/crp/1567555800

Recommended Citation

APPLEBACH E. Fecal microbiota therapy in recurrent and refractory clostridium difficile infections has been associated with positive results in immunocompromised patients. Clin. Res. Prac. 2019 Sep 18;5(2):eP1931. doi: 10.22237/crp/1567555800